A Preliminary Randomised Controlled Trial using Standard Therapy Vs Mugard - A Preliminary RCT using Standard Therapy Vs Mugard v1

Royal Devon & Exeter Foundation Trust0 个研究点目标入组 16 人开始时间: 2010年6月17日最近更新: 2019年6月30日

适应症

试验速览

暂无简介。

•over the age of 18 years old
•With a diagnosis of head and neck cancer who are to receive at least 50Gy of radiotherapy, with or without concomitant / neoadjuvant chemotherapy and where fields include at least 50% of the oral cavity.
•With a diagnosis of Acute Myeloid Leukaemia (AML) or Acute Lymphoblastic Leukaemia (ALL) who are due to receive intensive chemotherapy
•Patients receiving high dose methotrexate
•Undergoing autologous stem cell transplantation
•Written informed consent as a positive
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Patients who
•Are unable to give written informed consent
•Are unable to comprehend or record the self-reporting questionnaires, which will be used to assess symptoms.
•Are allergic to any of the constituents of Mugard or standard therapy.
•Are expected to move to another institution before completion of this study.
•Show signs of existing oral mucositis before commencement of treatment
•Are under the age of 18 years

发起方

Royal Devon & Exeter Foundation Trust